ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 78 filers reported holding ENZO BIOCHEM INC in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $370,963 | -55.5% | 340,333 | -48.1% | 0.00% | – |
Q1 2024 | $832,860 | -17.9% | 655,795 | -10.1% | 0.00% | – |
Q4 2023 | $1,014,194 | -14.1% | 729,682 | -13.5% | 0.00% | – |
Q3 2023 | $1,180,257 | -49.4% | 843,086 | -33.5% | 0.00% | -100.0% |
Q2 2023 | $2,331,674 | -36.9% | 1,267,075 | -16.7% | 0.00% | 0.0% |
Q1 2023 | $3,697,381 | +160029.1% | 1,521,683 | -5.7% | 0.00% | 0.0% |
Q4 2022 | $2,309 | -99.9% | 1,614,450 | +1.3% | 0.00% | 0.0% |
Q3 2022 | $3,554,000 | +7.1% | 1,593,865 | -0.5% | 0.00% | 0.0% |
Q2 2022 | $3,317,000 | -28.3% | 1,602,375 | +0.5% | 0.00% | 0.0% |
Q1 2022 | $4,624,000 | -9.8% | 1,594,541 | -0.1% | 0.00% | -50.0% |
Q4 2021 | $5,126,000 | -6.8% | 1,596,839 | +2.7% | 0.00% | 0.0% |
Q3 2021 | $5,502,000 | +8.9% | 1,554,149 | -2.5% | 0.00% | 0.0% |
Q2 2021 | $5,053,000 | -10.1% | 1,594,061 | -2.4% | 0.00% | 0.0% |
Q1 2021 | $5,618,000 | +30.8% | 1,633,223 | -4.1% | 0.00% | 0.0% |
Q4 2020 | $4,294,000 | +5.8% | 1,703,788 | -11.4% | 0.00% | 0.0% |
Q3 2020 | $4,058,000 | -7.7% | 1,923,366 | -2.0% | 0.00% | 0.0% |
Q2 2020 | $4,396,000 | -15.9% | 1,962,709 | -5.0% | 0.00% | -33.3% |
Q1 2020 | $5,228,000 | -6.6% | 2,066,365 | -2.9% | 0.00% | +50.0% |
Q4 2019 | $5,597,000 | -27.5% | 2,128,200 | -0.7% | 0.00% | -33.3% |
Q3 2019 | $7,715,000 | +7.0% | 2,142,985 | +0.1% | 0.00% | 0.0% |
Q2 2019 | $7,213,000 | +25.6% | 2,140,479 | +1.7% | 0.00% | +50.0% |
Q1 2019 | $5,745,000 | +1.8% | 2,104,448 | +3.7% | 0.00% | -33.3% |
Q4 2018 | $5,643,000 | -32.9% | 2,030,043 | -0.6% | 0.00% | 0.0% |
Q3 2018 | $8,415,000 | -19.0% | 2,042,601 | +2.0% | 0.00% | -25.0% |
Q2 2018 | $10,393,000 | -6.1% | 2,002,571 | -0.8% | 0.00% | -20.0% |
Q1 2018 | $11,068,000 | -35.1% | 2,019,650 | -3.4% | 0.01% | -28.6% |
Q4 2017 | $17,042,000 | -24.2% | 2,090,963 | -2.7% | 0.01% | -30.0% |
Q3 2017 | $22,490,000 | +0.5% | 2,148,017 | +6.0% | 0.01% | 0.0% |
Q2 2017 | $22,376,000 | +45.8% | 2,026,647 | +10.5% | 0.01% | +42.9% |
Q1 2017 | $15,345,000 | +17.2% | 1,833,401 | -2.8% | 0.01% | 0.0% |
Q4 2016 | $13,093,000 | +35.9% | 1,886,532 | -0.3% | 0.01% | +40.0% |
Q3 2016 | $9,635,000 | -11.0% | 1,892,842 | +4.4% | 0.01% | -16.7% |
Q2 2016 | $10,829,000 | +41.6% | 1,813,930 | +7.9% | 0.01% | +20.0% |
Q1 2016 | $7,647,000 | +11.1% | 1,680,645 | +9.9% | 0.01% | +25.0% |
Q4 2015 | $6,882,000 | +39.6% | 1,529,369 | -1.7% | 0.00% | +33.3% |
Q3 2015 | $4,930,000 | -5.4% | 1,555,096 | -9.6% | 0.00% | 0.0% |
Q2 2015 | $5,210,000 | -2.0% | 1,719,631 | -4.6% | 0.00% | 0.0% |
Q1 2015 | $5,316,000 | -36.6% | 1,802,080 | -4.6% | 0.00% | -50.0% |
Q4 2014 | $8,383,000 | -15.7% | 1,888,054 | -2.2% | 0.01% | -14.3% |
Q3 2014 | $9,944,000 | -2.3% | 1,930,764 | -0.4% | 0.01% | 0.0% |
Q2 2014 | $10,180,000 | +24.9% | 1,939,198 | -1.0% | 0.01% | +16.7% |
Q1 2014 | $8,150,000 | +41.7% | 1,959,141 | -0.5% | 0.01% | +50.0% |
Q4 2013 | $5,751,000 | +15.8% | 1,969,685 | -0.0% | 0.00% | 0.0% |
Q3 2013 | $4,966,000 | +20.5% | 1,970,616 | -0.5% | 0.00% | 0.0% |
Q2 2013 | $4,121,000 | – | 1,981,453 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |